Perigon Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.88M Buy
22,583
+619
+3% +$50.9K 0.03% 416
2026
Q2
$1.46M Buy
21,964
+1,010
+5% +$85.5K 0.02% 474
2026
Q1
$2.08M Sell
20,954
-371
-2% -$48.4K 0.04% 370
2025
Q4
$2.59M Buy
21,325
+716
+3% +$89.8K 0.05% 314
2025
Q3
$2.31M Buy
20,609
+1,403
+7% +$164K 0.05% 320
2025
Q2
$2.57M Buy
19,206
+386
+2% +$42.4K 0.06% 285
2025
Q1
$1.27M Buy
18,820
+4,543
+32% +$312K 0.03% 399
2024
Q4
$828K Buy
14,277
+9,707
+212% +$904K 0.02% 497
2024
Q3
$717K Buy
4,570
+1,229
+37% +$189K 0.02% 515
2024
Q2
$503K Buy
+3,341
New +$401K 0.01% 531

Other funds holding TMDX

Perigon Wealth Management's TMDX Position: Q3 2026 in Review

Perigon Wealth Management increased its Transmedics (TMDX) stake by 2.8% in Q3 2026, buying an estimated $50.9K and bringing the position to 22,583 shares worth $1.88M. The position accounts for 0.03% of the portfolio, ranked #416.

Perigon Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.59M in Q4 2025. 72 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Perigon Wealth Management held 22,583 shares of Transmedics worth $1.88M as of Q3 2026.
  • Perigon Wealth Management bought 619 Transmedics shares in Q3 2026, an estimated $50.9K.
  • Transmedics made up 0.03% of Perigon Wealth Management's portfolio in Q3 2026, its #416 holding.
  • Perigon Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 10 quarters since.
  • Perigon Wealth Management's Transmedics position peaked at $2.59M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.